CD8A and neoplasm: In TCR transgenic OT-1 mice, in which greater than 95% of the T-cells have TCRs specific for ovalbumin (OVA), vaccination with OVA produced OT-1 CD8+ T-cells which were able to lyse OVA-expressing EG7 tumor cells but not the OVA-negative EL4 parental cell line.